Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Aging (Individuals) | 2 |
| Alzheimers Disease | 2 |
| Brain Hemisphere Functions | 2 |
| Task Analysis | 2 |
| Animals | 1 |
| Biochemistry | 1 |
| Cognitive Ability | 1 |
| Comparative Analysis | 1 |
| Cytology | 1 |
| Decision Making | 1 |
| Eye Movements | 1 |
| More ▼ | |
Source
| Learning & Memory | 2 |
Author
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkHaque, Rafi U.; Manzanares, Cecelia M.; Brown, Lavonda N.; Pongos, Alvince L.; Lah, James J.; Clifford, Gari D.; Levey, Allan I. – Learning & Memory, 2019
The entorhinal-hippocampal circuit is one of the earliest sites of cortical pathology in Alzheimer's disease (AD). Visuospatial memory paradigms that are mediated by the entorhinal-hippocampal circuit may offer a means to detect memory impairment during the early stages of AD. In this study, we developed a 4-min visuospatial memory paradigm called…
Descriptors: Alzheimers Disease, Memory, Visual Perception, Spatial Ability
Guzman-Ramos, Kioko; Moreno-Castilla, Perla; Castro-Cruz, Monica; McGaugh, James L.; Martinez-Coria, Hilda; LaFerla, Frank M.; Bermudez-Rattoni, Federico – Learning & Memory, 2012
Previous findings indicate that the acquisition and consolidation of recognition memory involves dopaminergic activity. Although dopamine deregulation has been observed in Alzheimer's disease (AD) patients, the dysfunction of this neurotransmitter has not been investigated in animal models of AD. The aim of this study was to assess, by in vivo…
Descriptors: Alzheimers Disease, Animals, Recognition (Psychology), Patients
